Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
13%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_3
1
11%
Ph not_applicable
4
44%
Ph phase_1
1
11%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(8)
Terminated(1)

Detailed Status

Completed8
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
88.9%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 31 (16.7%)
N/A4 (66.7%)

Trials by Status

terminated111%
completed889%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_1

Vaccine Therapy in Preventing HPV in HIV-Positive Women in India

NCT00667563
terminated

Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma

NCT02928510
completed

Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials

NCT00695422
completednot_applicable

Comparison of Screening Tests in Detecting Cervical Neoplasia

NCT00039312
completednot_applicable

Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia

NCT00602368
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT00667563Phase 1

Vaccine Therapy in Preventing HPV in HIV-Positive Women in India

Completed
NCT02928510

Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma

Terminated
NCT00695422

Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials

Completed
NCT00039312Not Applicable

Comparison of Screening Tests in Detecting Cervical Neoplasia

Completed
NCT00602368Not Applicable

Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia

Completed
NCT00462813Phase 3

Diindolylmethane in Treating Patients With Abnormal Cervical Cells

Completed
NCT00084903Not Applicable

Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears

Completed
NCT00004091

Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results

Completed
NCT00632190Not Applicable

Spectroscopy in Diagnosing Dysplasia and Neoplasia in the Cervix in Women Undergoing Colposcopy

Completed

All 9 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
9